N/A
N=4,856
Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics
Diabetes Mellitus · Cardiovascular Diseases
Bottom Line
View on ClinicalTrials.gov: NCT02299791 ↗Enrolled (actual)
4,856
Serious AEs
—
Results posted
Oct 2017
Primary outcome: Primary: Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both — 1279; 1318 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ALL (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Kaiser Permanente
- Primary completion
- May 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both |
1279; 1318 | — |
Summary
The purpose of the ALL Study is to determine the effectiveness of the dissemination of the ALL intervention from an integrated care setting into Community Health Centers (CHCs) by measuring changes in diabetes mellitus (DM) population prescription rates for the medications, using a pre-post comparison within clinics and a staggered, randomized implementation across clinics.
Eligibility Criteria
Inclusion Criteria
- Convenience sample of 11 community health clinics (CHCs) that are members of OCHIN, Inc.
Exclusion Criteria
- none, for study CHCs
Data sourced from ClinicalTrials.gov (NCT02299791). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.